Use of Biodesign® Otologic Graft in Tympanoplasty
- Conditions
- Tympanic Membrane Perforation
- Interventions
- Biological: Biodesign Otologic graftOther: Autologous temporalis fascia
- Registration Number
- NCT03904316
- Lead Sponsor
- Ascension South East Michigan
- Brief Summary
This is a prospective, randomized trial to evaluate tympanoplasty outcomes using Biodesign SIS graft compared to autologous temporalis fascia, the most commonly used graft for repair of tympanic membrane.
- Detailed Description
Patients 18 years or older will undergo primary tympanoplasty without mastoidectomy. The patients will be randomized into groups receiving Biodesign versus autograft temporalis fascia for repair.
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
- Patients undergoing primary tympanoplasty without mastoidectomy.
- Patients with a known biologic sensitivity or a cultural objection to use of porcine materials.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Biodesign graft tympanic membrane repair Biodesign Otologic graft Patient's perforated tympanic membrane will be repaired with an acellular matrix derived from porcine small intestine submucosa, Biodesign Otologic graft Autograft tympanic membrane repair Autologous temporalis fascia Patient's perforated tympanic membrane will be repaired with autologous temporalis fascia.
- Primary Outcome Measures
Name Time Method Assessment of graft take after tympanoplasty 6 months postoperatively by the surgeon Microscopically evaluate tympanic membrane for perforation closure
- Secondary Outcome Measures
Name Time Method Measurement of Hearing Parameters Measure hearing parameters 6 months postoperatively The word recognition testing evaluates the patient's ability to repeat phonetically balanced words appropriate for his/her hearing level.
Trial Locations
- Locations (1)
Ascension Providence Hospital, Novi Campus
🇺🇸Novi, Michigan, United States